CBIO FY 2013 Earnings — Crescent Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

CBIOCrescent Biopharma, Inc.

$334M

FY 2013 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M-73.8% YoY

Gross Profit

$4M100.0% margin

Operating Income

-$11M-265.7% margin

Net Income

-$11M-265.6% margin

EPS (Diluted)

$-8.87

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$16M

Stock-Based Comp.

$425,689

Balance Sheet

Total Assets

$5M

Total Liabilities

$2M

Stockholders' Equity

$3M

Cash & Equivalents

$2M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$15M	-73.8%
Gross Profit	$4M	$15M	-73.8%
Operating Income	-$11M	$4M	-391.8%
Net Income	-$11M	$4M	-390.1%